{"pmid":32317114,"title":"An academic allergy unit during COVID-19 pandemic in Italy.","text":["An academic allergy unit during COVID-19 pandemic in Italy.","J Allergy Clin Immunol","Malipiero, Giacomo","Paoletti, Giovanni","Puggioni, Francesca","Racca, Francesca","Ferri, Sebastian","Marsala, Antonino","Leoncini, Ornella","Porli, Monica","Pieri, Gabriella","Canonica, Giorgio Walter","Heffler, Enrico","32317114"],"journal":"J Allergy Clin Immunol","authors":["Malipiero, Giacomo","Paoletti, Giovanni","Puggioni, Francesca","Racca, Francesca","Ferri, Sebastian","Marsala, Antonino","Leoncini, Ornella","Porli, Monica","Pieri, Gabriella","Canonica, Giorgio Walter","Heffler, Enrico"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32317114","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaci.2020.04.003","source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664815087774334977,"score":8.518259,"similar":[{"pmid":32224232,"title":"COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.","text":["COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic.","In the event of a global infectious pandemic, drastic measures may be needed that limit or require adjustment of ambulatory allergy services. However, no rationale for how to prioritize service shut down and patient care exists. A consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily triage allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted modified Delphi methodology to achieve consensus. During the ongoing pandemic while social distancing is being encouraged, most allergy/immunology care could be postponed/delayed or handled through virtual care. With the exception of many patients with primary immunodeficiency, patients on venom immunotherapy, and patients with asthma of a certain severity, there is limited need for face-to-face visits under such conditions. These suggestions are intended to help provide a logical approach to quickly adjust service to mitigate risk to both medical staff and patients. Importantly, individual community circumstances may be unique and require contextual consideration. The decision to enact any of these measures rests with the judgment of each clinician and individual health care system. Pandemics are unanticipated, and enforced social distancing/quarantining is highly unusual. This expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so.","J Allergy Clin Immunol Pract","Shaker, Marcus S","Oppenheimer, John","Grayson, Mitchell","Stukus, David","Hartog, Nicholas","Hsieh, Elena W Y","Rider, Nicholas","Dutmer, Cullen M","Vander Leek, Timothy K","Kim, Harold","Chan, Edmond S","Mack, Doug","Ellis, Anne K","Lang, David","Lieberman, Jay","Fleischer, David","Golden, David B K","Wallace, Dana","Portnoy, Jay","Mosnaim, Giselle","Greenhawt, Matthew","32224232"],"abstract":["In the event of a global infectious pandemic, drastic measures may be needed that limit or require adjustment of ambulatory allergy services. However, no rationale for how to prioritize service shut down and patient care exists. A consensus-based ad-hoc expert panel of allergy/immunology specialists from the United States and Canada developed a service and patient prioritization schematic to temporarily triage allergy/immunology services. Recommendations and feedback were developed iteratively, using an adapted modified Delphi methodology to achieve consensus. During the ongoing pandemic while social distancing is being encouraged, most allergy/immunology care could be postponed/delayed or handled through virtual care. With the exception of many patients with primary immunodeficiency, patients on venom immunotherapy, and patients with asthma of a certain severity, there is limited need for face-to-face visits under such conditions. These suggestions are intended to help provide a logical approach to quickly adjust service to mitigate risk to both medical staff and patients. Importantly, individual community circumstances may be unique and require contextual consideration. The decision to enact any of these measures rests with the judgment of each clinician and individual health care system. Pandemics are unanticipated, and enforced social distancing/quarantining is highly unusual. This expert panel consensus document offers a prioritization rational to help guide decision making when such situations arise and an allergist/immunologist is forced to reduce services or makes the decision on his or her own to do so."],"journal":"J Allergy Clin Immunol Pract","authors":["Shaker, Marcus S","Oppenheimer, John","Grayson, Mitchell","Stukus, David","Hartog, Nicholas","Hsieh, Elena W Y","Rider, Nicholas","Dutmer, Cullen M","Vander Leek, Timothy K","Kim, Harold","Chan, Edmond S","Mack, Doug","Ellis, Anne K","Lang, David","Lieberman, Jay","Fleischer, David","Golden, David B K","Wallace, Dana","Portnoy, Jay","Mosnaim, Giselle","Greenhawt, Matthew"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32224232","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.jaip.2020.03.012","keywords":["allergic rhinitis","allergy","allergy immunotherapy","angioedema","asthma","atopic dermatitis","covid-19","food allergy","primary immunodeficiency","sars-cov-2","urticaria","venom allergy"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["United States","Canada"],"countries":["Canada","United States"],"countries_codes":["CAN|Canada","USA|United States"],"_version_":1664640912819486720,"score":54.08954},{"pmid":32249660,"title":"The Effects of COVID-19 on Academic Activities and Surgical Education in Italy.","text":["The Effects of COVID-19 on Academic Activities and Surgical Education in Italy.","J Invest Surg","Gallo, Gaetano","Trompetto, Mario","32249660"],"journal":"J Invest Surg","authors":["Gallo, Gaetano","Trompetto, Mario"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32249660","week":"202015|Apr 06 - Apr 12","doi":"10.1080/08941939.2020.1748147","source":"PubMed","locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"weight":0,"_version_":1663352136266678273,"score":48.61978},{"pmid":32319129,"title":"Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic.","text":["Managing childhood allergies and immunodeficiencies during respiratory virus epidemics - the 2020 COVID-19 pandemic.","While the world is facing an unprecedented pandemic with COVID-19, patients with chronic diseases need special attention and if warranted adaptation of their regular treatment plan. In children, allergy and asthma are among the most prevalent non-communicable chronic diseases, and health care providers taking care of these patients need guidance. At the current stage of knowledge, children have less severe symptoms of COVID-19, and severe asthma and immunodeficiency are classified as risk factors. In addition, there is no evidence that currently available asthma and allergy treatments, including antihistamines, corticosteroids, bronchodilators increase the risk of severe disease from COVID-19. Most countries affected by COVID-19 have opted for nationwide confinement, which means that communication with the primary clinician is often performed by telemedicine. Optimal disease control of allergic, asthmatic and immunodeficient children should be sought according to usual treatment guidelines. This statement of the EAACI Section on Pediatrics puts forward six recommendations for the management of childhood allergies and immunodeficiencies based on six underlying facts and existing evidence.","Pediatr Allergy Immunol","Brough, Helen A","Kalayci, Omer","Sediva, Anna","Untersmayr, Eva","Munblit, Daniel","Rodriquez Del Rio, Pablo","Vazquez-Ortiz, Marta","Arasi, Stefania","Alvaro-Lozano, Montserrat","Tsabouri, Sophia","Galli, Elena","Beken, Burcin","Eigenmann, Philippe A","32319129"],"abstract":["While the world is facing an unprecedented pandemic with COVID-19, patients with chronic diseases need special attention and if warranted adaptation of their regular treatment plan. In children, allergy and asthma are among the most prevalent non-communicable chronic diseases, and health care providers taking care of these patients need guidance. At the current stage of knowledge, children have less severe symptoms of COVID-19, and severe asthma and immunodeficiency are classified as risk factors. In addition, there is no evidence that currently available asthma and allergy treatments, including antihistamines, corticosteroids, bronchodilators increase the risk of severe disease from COVID-19. Most countries affected by COVID-19 have opted for nationwide confinement, which means that communication with the primary clinician is often performed by telemedicine. Optimal disease control of allergic, asthmatic and immunodeficient children should be sought according to usual treatment guidelines. This statement of the EAACI Section on Pediatrics puts forward six recommendations for the management of childhood allergies and immunodeficiencies based on six underlying facts and existing evidence."],"journal":"Pediatr Allergy Immunol","authors":["Brough, Helen A","Kalayci, Omer","Sediva, Anna","Untersmayr, Eva","Munblit, Daniel","Rodriquez Del Rio, Pablo","Vazquez-Ortiz, Marta","Arasi, Stefania","Alvaro-Lozano, Montserrat","Tsabouri, Sophia","Galli, Elena","Beken, Burcin","Eigenmann, Philippe A"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32319129","week":"202017|Apr 20 - Apr 26","doi":"10.1111/pai.13262","keywords":["covid-19","sars-cov-2","allergy","asthma","biologics","children","coronavirus","corticosteroids","immunodeficiency","treatment"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["Optimal"],"_version_":1664815087837249536,"score":47.483032},{"pmid":32153144,"pmcid":"PMC7113449","title":"COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis.","text":["COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis.","Infect Chemother","Song, Young Goo","Shin, Hyoung Shik","32153144"],"journal":"Infect Chemother","authors":["Song, Young Goo","Shin, Hyoung Shik"],"date":"2020-03-11T11:00:00Z","year":2020,"_id":"32153144","week":"202011|Mar 09 - Mar 15","doi":"10.3947/ic.2020.52.1.110","keywords":["covid-19","coronavirus","hypersensitivity pneumonitis","sars-cov-2"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1664640874846355457,"score":46.95494},{"pmid":32243877,"title":"Running a virtual allergy division and training program in the time of COVID-19 pandemic.","text":["Running a virtual allergy division and training program in the time of COVID-19 pandemic.","J Allergy Clin Immunol","Codispoti, Christopher D","Bandi, Sindhura","Moy, James","Mahdavinia, Mahboobeh","32243877"],"journal":"J Allergy Clin Immunol","authors":["Codispoti, Christopher D","Bandi, Sindhura","Moy, James","Mahdavinia, Mahboobeh"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243877","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.jaci.2020.03.018","keywords":["covid-19","allergy division","pandemic","training program","virtual"],"source":"PubMed","weight":0,"_version_":1664638249417572352,"score":44.514267}]}